Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population

被引：18

作者：

Alonso, G. Todd ^{[1
]}

Triolo, Taylor M. ^{[1
]}

Akturk, Halis Kaan ^{[1
]}

Pauley, Meghan E. ^{[1
]}

Sobczak, Marisa ^{[2
]}

Forlenza, Gregory P. ^{[1
]}

Sakamoto, Casey ^{[1
]}

Pyle, Laura ^{[1
,3
]}

Frohnert, Brigitte I. ^{[1
]}

机构：

[1] Univ Colorado, Barbara Davis Ctr, Anschutz Med Campus, Aurora, CO 80045 USA

[2] Univ Colorado, Sch Med, Anschutz Med Campus, Aurora, CO USA

[3] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA

来源：

DIABETES CARE | 2023年 / 46卷 / 06期

基金：

美国国家卫生研究院;

关键词：

RANDOMIZED-TRIAL; ADOLESCENTS; CHILDREN;

D O I：

10.2337/dc22-2121

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OBJECTIVEWhile continuous glucose monitors (CGMs), insulin pumps, and hybrid closed-loop (HCL) systems each improve glycemic control in type 1 diabetes, it is unclear how the use of these technologies impacts real-world pediatric care. RESEARCH DESIGN AND METHODSWe found 1,455 patients aged <22 years, with type 1 diabetes duration >3 months, and who had data from a single center in between both 2016-2017 (n = 2,827) and 2020-2021 (n = 2,731). Patients were grouped by multiple daily injections or insulin pump, with or without an HCL system, and using a blood glucose monitor or CGM. Glycemic control was compared using linear mixed-effects models adjusting for age, diabetes duration, and race/ethnicity. RESULTSCGM use increased from 32.9 to 75.3%, and HCL use increased from 0.3 to 27.9%. Overall A1C decreased from 8.9 to 8.6% (P < 0.0001). CONCLUSIONSAdoption of CGM and HCL was associated with decreased A1C, suggesting promotion of these technologies may yield glycemic benefits.

引用

页码：1218 / 1222

页数：6

共 16 条

[1] Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system
Berget, Cari
Messer, Laurel H.
Vigers, Tim
Frohnert, Brigitte I.
Pyle, Laura
Wadwa, R. Paul
Driscoll, Kimberly A.
Forlenza, Gregory P.
[J]. PEDIATRIC DIABETES, 2020, 21 (02) : 310 - 318
[2] Socioeconomic Disparities in Health in the United States: What the Patterns Tell Us
Braveman, Paula A.
Cubbin, Catherine
Egerter, Susan
Williams, David R.
Pamuk, Elsie
[J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2010, 100 : S186 - S196
[3] A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
Breton, Marc D.
Kanapka, Lauren G.
Beck, Roy W.
Ekhlaspour, Laya
Forlenza, Gregory P.
Cengiz, Eda
Schoelwer, Melissa
Ruedy, Katrina J.
Jost, Emily
Carria, Lori
Emory, Emma
Hsu, Liana J.
Oliveri, Mary
Kollman, Craig C.
Dokken, Betsy B.
Weinzimer, Stuart A.
DeBoer, Mark D.
Buckingham, Bruce A.
Chernavvsky, Daniel
Wadwa, R. Paul
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (09) : 836 - 845
[4] Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A.
Kovatchev, B. P.
Raghinaru, D.
Lum, J. W.
Buckingham, B. A.
Kudva, Y. C.
Laffel, L. M.
Levy, C. J.
Pinsker, J. E.
Wadwa, R. P.
Dassau, E.
Doyle, F. J., III
Anderson, S. M.
Church, M. M.
Dadlani, V
Ekhlaspour, L.
Forlenza, G. P.
Isganaitis, E.
Lam, D. W.
Kollman, C.
Beck, R. W.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18) : 1707 - 1717
[5] Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Brown, Sue A.
Forlenza, Gregory P.
Bode, Bruce W.
Pinsker, Jordan E.
Levy, Carol J.
Criego, Amy B.
Hansen, David W.
Hirsch, Irl B.
Carlson, Anders L.
Bergenstal, Richard M.
Sherr, Jennifer L.
Mehta, Sanjeev N.
Laffel, Lori M.
Shah, Viral N.
Bhargava, Anuj
Weinstock, Ruth S.
MacLeish, Sarah A.
DeSalvo, Daniel J.
Jones, Thomas C.
Aleppo, Grazia
Buckingham, Bruce A.
Ly, Trang T.
[J]. DIABETES CARE, 2021, 44 (07) : 1630 - 1640
[6] Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET
Cardona-Hernandez, Roque
Schwandt, Anke
Alkandari, Hessa
Bratke, Heiko
Chobot, Agata
Coles, Nicole
Corathers, Sarah
Goksen, Damla
Goss, Peter
Imane, Zineb
Nagl, Katrin
O'Riordan, Stephen M. P.
Jefferies, Craig
[J]. DIABETES CARE, 2021, 44 (05) : 1176 - 1184
[7] Performance of Medtronic Hybrid Closed-Loop Iterations, Results from a Randomized Trial in Adolescents with Type 1 Diabetes
de Bock, Martin
Dart, Julie
Hancock, Michael
Smith, Grant
Davis, Elizabeth A.
Jones, Timothy W.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (10) : 693 - 697
[8] Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative
DeSalvo, Daniel J.
Lanzinger, Stefanie
Noor, Nudrat
Steigleder-Schweiger, Claudia
Ebekozien, Osagie
von Sengbusch, Simone
Jones, Nana-Hawa Yayah
Laubner, Katharina
Maahs, David M.
Holl, Reinhard W.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (12) : 920 - 924
[9] Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial
Forlenza, Gregory P.
Ekhlaspour, Laya
DiMeglio, Linda A.
Fox, Larry A.
Rodriguez, Henry
Shulman, Dorothy I.
Kaiserman, Kevin B.
Liljenquist, David R.
Shin, John
Lee, Scott W.
Buckingham, Bruce A.
[J]. PEDIATRIC DIABETES, 2022, 23 (03) : 324 - 329
[10] Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes
Forlenza, Gregory P.
Pinhas-Hamiel, Orit
Liljenquist, David R.
Shulman, Dorothy I.
Bailey, Timothy S.
Bode, Bruce W.
Wood, Michael A.
Buckingham, Bruce A.
Kaiserman, Kevin B.
Shin, John
Huang, Suiying
Lee, Scott W.
Kaufman, Francine R.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (01) : 11 - 19

← 1 2 →